Mattias Westman
Angel Investor
Stockholm, Sweden
Mattias Westman is a Series A investor in Stockholm focused on Health Care and Biotechnology. Mattias Westman is the Founding Partner of Prosperity Capital Management, an investment firm specializing in Russia and the former Soviet Union. PCM is an active investor with assets of some 2.8bn USD. Prior to founding PCM in 1996, he worked for investment banks Hagströmer & Qviberg and Alfred Berg and started investing in Russia in 1993.Westman has also served on the boards of several Russian companies and as Deputy Chairman of the Investor Protection Association in Russia. He holds a masters degree from the Stockholm School of Economics.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Mattias Westman invests in
Stages Mattias Westman invests in
Countries Mattias Westman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Biotechnology 2 (50%)
- SMS 1 (25%)
- Medical 1 (25%)
- Facebook 1 (25%)
Stage
- Series A 1 (25%)
- Series C 1 (25%)
- Series D 1 (25%)
- Debt Financing 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. | $25M / Series A / Jul 27, 2021 | ||
| ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing. The company is actively conducting multiple clinical trials to explore the efficacy of their cancer detection methods, welcoming eligible participants. The company's approach relies on epigenomics, tracking gene activity todetect changes in cells indicative of cancer. | $70M / Series C / May 12, 2021 | ||
| Tetrapod Software LLC offers Chatbox, an enterprise collaboration solution. | $2.1M / Debt Financing / Dec 18, 2015 | ||
| ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing. The company is actively conducting multiple clinical trials to explore the efficacy of their cancer detection methods, welcoming eligible participants. The company's approach relies on epigenomics, tracking gene activity todetect changes in cells indicative of cancer. | $52M / Series D |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mattias Westman invest in?
Mattias Westman invests primarily in Health Care, Biotechnology and SMS startups, most often at Series A and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mattias Westman?
Public channels for Mattias Westman include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mattias Westman last invest?
The most recent investment recorded for Mattias Westman closed in Jul 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
